

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.11147339 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.95336624 |
| 3 | glutamate secretion (GO:0014047) | 5.68172434 |
| 4 | vocalization behavior (GO:0071625) | 5.62366702 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.56621244 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.43582766 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.38530237 |
| 8 | synaptic vesicle maturation (GO:0016188) | 5.34904694 |
| 9 | behavioral response to nicotine (GO:0035095) | 5.34063505 |
| 10 | locomotory exploration behavior (GO:0035641) | 5.32365093 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.30020767 |
| 12 | neuron cell-cell adhesion (GO:0007158) | 5.26926013 |
| 13 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.26514666 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.06919749 |
| 15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.97123096 |
| 16 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.95337849 |
| 17 | protein localization to synapse (GO:0035418) | 4.90125972 |
| 18 | neurotransmitter secretion (GO:0007269) | 4.69894451 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.68976089 |
| 20 | neuronal action potential propagation (GO:0019227) | 4.67292157 |
| 21 | serotonin metabolic process (GO:0042428) | 4.63923520 |
| 22 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.63630568 |
| 23 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.38003667 |
| 24 | ATP synthesis coupled proton transport (GO:0015986) | 4.38003667 |
| 25 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.34837689 |
| 26 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.33768485 |
| 27 | exploration behavior (GO:0035640) | 4.23830215 |
| 28 | presynaptic membrane assembly (GO:0097105) | 4.21550304 |
| 29 | NADH dehydrogenase complex assembly (GO:0010257) | 4.15493766 |
| 30 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.15493766 |
| 31 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.15493766 |
| 32 | synaptic transmission, glutamatergic (GO:0035249) | 4.15251184 |
| 33 | neuronal action potential (GO:0019228) | 4.13187986 |
| 34 | histone H4-K12 acetylation (GO:0043983) | 4.10865271 |
| 35 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.09863789 |
| 36 | neuron-neuron synaptic transmission (GO:0007270) | 4.08900130 |
| 37 | primary amino compound metabolic process (GO:1901160) | 4.04935460 |
| 38 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.04797449 |
| 39 | glutamate receptor signaling pathway (GO:0007215) | 3.97554178 |
| 40 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.94152947 |
| 41 | postsynaptic membrane organization (GO:0001941) | 3.92475243 |
| 42 | proline transport (GO:0015824) | 3.90957406 |
| 43 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.87319124 |
| 44 | gamma-aminobutyric acid transport (GO:0015812) | 3.86332192 |
| 45 | presynaptic membrane organization (GO:0097090) | 3.84601048 |
| 46 | long-term synaptic potentiation (GO:0060291) | 3.83137402 |
| 47 | protein complex biogenesis (GO:0070271) | 3.82918304 |
| 48 | neurotransmitter transport (GO:0006836) | 3.82885793 |
| 49 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.81203362 |
| 50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.80988675 |
| 51 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.80476017 |
| 52 | chaperone-mediated protein transport (GO:0072321) | 3.75917994 |
| 53 | positive regulation of membrane potential (GO:0045838) | 3.72387579 |
| 54 | regulation of neurotransmitter secretion (GO:0046928) | 3.71167815 |
| 55 | regulation of synapse structural plasticity (GO:0051823) | 3.69562572 |
| 56 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.63719211 |
| 57 | regulation of postsynaptic membrane potential (GO:0060078) | 3.62747723 |
| 58 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.58976699 |
| 59 | long-term memory (GO:0007616) | 3.58019253 |
| 60 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.56573121 |
| 61 | regulation of synaptic plasticity (GO:0048167) | 3.52388299 |
| 62 | neuron recognition (GO:0008038) | 3.50934843 |
| 63 | regulation of neurotransmitter levels (GO:0001505) | 3.49613289 |
| 64 | electron transport chain (GO:0022900) | 3.45358513 |
| 65 | respiratory electron transport chain (GO:0022904) | 3.43704614 |
| 66 | otic vesicle formation (GO:0030916) | 3.43241152 |
| 67 | synaptic vesicle endocytosis (GO:0048488) | 3.42096097 |
| 68 | positive regulation of synapse maturation (GO:0090129) | 3.41455102 |
| 69 | activation of protein kinase A activity (GO:0034199) | 3.41086662 |
| 70 | regulation of neurotransmitter transport (GO:0051588) | 3.40004749 |
| 71 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.37688734 |
| 72 | regulation of gene silencing by miRNA (GO:0060964) | 3.37688734 |
| 73 | regulation of gene silencing by RNA (GO:0060966) | 3.37688734 |
| 74 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.35878395 |
| 75 | layer formation in cerebral cortex (GO:0021819) | 3.35230241 |
| 76 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.33333658 |
| 77 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.32654844 |
| 78 | response to histamine (GO:0034776) | 3.31918297 |
| 79 | dendritic spine morphogenesis (GO:0060997) | 3.27192072 |
| 80 | cerebellar granule cell differentiation (GO:0021707) | 3.22985151 |
| 81 | startle response (GO:0001964) | 3.22025735 |
| 82 | positive regulation of neurotransmitter transport (GO:0051590) | 3.21363989 |
| 83 | regulation of vesicle fusion (GO:0031338) | 3.21260548 |
| 84 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.19866498 |
| 85 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.19749060 |
| 86 | positive regulation of action potential (GO:0045760) | 3.19159241 |
| 87 | axonal fasciculation (GO:0007413) | 3.17454115 |
| 88 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.16309106 |
| 89 | positive regulation of synaptic transmission (GO:0050806) | 3.16280633 |
| 90 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.15915512 |
| 91 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.15758599 |
| 92 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.15521542 |
| 93 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.15521542 |
| 94 | transmission of nerve impulse (GO:0019226) | 3.15451233 |
| 95 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.13360124 |
| 96 | membrane depolarization (GO:0051899) | 3.12808964 |
| 97 | membrane hyperpolarization (GO:0060081) | 3.12769111 |
| 98 | dopaminergic neuron differentiation (GO:0071542) | 3.11897981 |
| 99 | cellular potassium ion homeostasis (GO:0030007) | 3.11299286 |
| 100 | regulation of synaptic transmission (GO:0050804) | 3.09753012 |
| 101 | viral transcription (GO:0019083) | 3.09305025 |
| 102 | * synaptic transmission (GO:0007268) | 3.08041107 |
| 103 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.07256748 |
| 104 | urinary tract smooth muscle contraction (GO:0014848) | 3.06940490 |
| 105 | translational termination (GO:0006415) | 3.06743651 |
| 106 | neuromuscular process controlling posture (GO:0050884) | 3.04080866 |
| 107 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.03358959 |
| 108 | transferrin transport (GO:0033572) | 3.02771656 |
| 109 | positive regulation of synapse assembly (GO:0051965) | 3.02533424 |
| 110 | spinal cord motor neuron differentiation (GO:0021522) | 3.01377658 |
| 111 | innervation (GO:0060384) | 2.99769674 |
| 112 | synapse assembly (GO:0007416) | 2.99668620 |
| 113 | detection of calcium ion (GO:0005513) | 2.99068032 |
| 114 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.98259978 |
| 115 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.98259978 |
| 116 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.98259978 |
| 117 | auditory behavior (GO:0031223) | 2.97206432 |
| 118 | indole-containing compound metabolic process (GO:0042430) | 2.96795486 |
| 119 | learning (GO:0007612) | 2.95131875 |
| 120 | synaptic vesicle transport (GO:0048489) | 2.94572471 |
| 121 | establishment of synaptic vesicle localization (GO:0097480) | 2.94572471 |
| 122 | spliceosomal complex assembly (GO:0000245) | 2.94003643 |
| 123 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.93874131 |
| 124 | sulfation (GO:0051923) | 2.92018696 |
| 125 | mechanosensory behavior (GO:0007638) | 2.91853803 |
| 126 | membrane depolarization during action potential (GO:0086010) | 2.91723071 |
| 127 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.90049418 |
| 128 | dopamine biosynthetic process (GO:0042416) | 2.89670966 |
| 129 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.86306891 |
| 130 | calcium ion-dependent exocytosis (GO:0017156) | 2.85399950 |
| 131 | response to auditory stimulus (GO:0010996) | 2.85179814 |
| 132 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.83367453 |
| 133 | regulation of respiratory system process (GO:0044065) | 2.83267752 |
| 134 | response to pheromone (GO:0019236) | 2.82557455 |
| 135 | fear response (GO:0042596) | 2.82540796 |
| 136 | ferric iron transport (GO:0015682) | 2.82324647 |
| 137 | trivalent inorganic cation transport (GO:0072512) | 2.82324647 |
| 138 | hindbrain development (GO:0030902) | 2.81502958 |
| 139 | cell proliferation in forebrain (GO:0021846) | 2.80929068 |
| 140 | action potential (GO:0001508) | 2.80385359 |
| 141 | peristalsis (GO:0030432) | 2.80070276 |
| 142 | kidney morphogenesis (GO:0060993) | 2.77692192 |
| 143 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.71526106 |
| 144 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.67456213 |
| 145 | behavioral response to ethanol (GO:0048149) | 2.66089926 |
| 146 | neuronal stem cell maintenance (GO:0097150) | 2.64606783 |
| 147 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.63800183 |
| 148 | intracellular protein transmembrane import (GO:0044743) | 2.60963309 |
| 149 | mitochondrion morphogenesis (GO:0070584) | 2.59491304 |
| 150 | organ growth (GO:0035265) | 2.58095511 |
| 151 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.57862276 |
| 152 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.57862276 |
| 153 | nephron epithelium morphogenesis (GO:0072088) | 2.57768412 |
| 154 | nephron tubule morphogenesis (GO:0072078) | 2.57768412 |
| 155 | pseudouridine synthesis (GO:0001522) | 2.57652360 |
| 156 | lateral sprouting from an epithelium (GO:0060601) | 2.56239240 |
| 157 | ovulation cycle (GO:0042698) | 2.56014997 |
| 158 | hydrogen ion transmembrane transport (GO:1902600) | 2.55904694 |
| 159 | regulation of action potential (GO:0098900) | 2.52393323 |
| 160 | proteasome assembly (GO:0043248) | 2.51091308 |
| 161 | cochlea development (GO:0090102) | 2.50299674 |
| 162 | artery development (GO:0060840) | 2.49404710 |
| 163 | behavioral response to cocaine (GO:0048148) | 2.49027403 |
| 164 | ATP biosynthetic process (GO:0006754) | 2.45925410 |
| 165 | neurofilament cytoskeleton organization (GO:0060052) | 2.43574439 |
| 166 | somite development (GO:0061053) | 2.43467763 |
| 167 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.43100570 |
| 168 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.42856563 |
| 169 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.42766309 |
| 170 | termination of RNA polymerase III transcription (GO:0006386) | 2.42766309 |
| 171 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.41746973 |
| 172 | positive regulation of mRNA processing (GO:0050685) | 2.41603904 |
| 173 | proton transport (GO:0015992) | 2.40776144 |
| 174 | platelet dense granule organization (GO:0060155) | 2.39846200 |
| 175 | synaptic transmission, cholinergic (GO:0007271) | 2.39142859 |
| 176 | hydrogen transport (GO:0006818) | 2.36334284 |
| 177 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.35389527 |
| 178 | protein neddylation (GO:0045116) | 2.35202648 |
| 179 | cotranslational protein targeting to membrane (GO:0006613) | 2.34209818 |
| 180 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.33970449 |
| 181 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.33970449 |
| 182 | nucleobase catabolic process (GO:0046113) | 2.31797582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.98281501 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.10345354 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.19734699 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.06918270 |
| 5 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.02554132 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.98875401 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65490633 |
| 8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.65123629 |
| 9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.60489741 |
| 10 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.60489741 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58024840 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.57139446 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.50695839 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.49421883 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.43848993 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.42352703 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.38532752 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.35642234 |
| 19 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.23704836 |
| 20 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.21349725 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.18474043 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.17393499 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.15960062 |
| 24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.15608440 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.12772508 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.12650470 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.08644539 |
| 28 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.03085281 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.02810272 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.01790602 |
| 31 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.00561329 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.95854593 |
| 33 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.95704733 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.89320358 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.85439598 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.84138009 |
| 37 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.82198970 |
| 38 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72075800 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70945833 |
| 40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.67511417 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.66995233 |
| 42 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.66873928 |
| 43 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66702286 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.60154059 |
| 45 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.57983961 |
| 46 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.54913195 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51982101 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49982882 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.45633220 |
| 50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.44953333 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44648731 |
| 52 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44512352 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.43649412 |
| 54 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.42288118 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41664924 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.40686057 |
| 57 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.40017031 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.40013099 |
| 59 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38972701 |
| 60 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38699268 |
| 61 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38235683 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37903872 |
| 63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.37609090 |
| 64 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.36290172 |
| 65 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34484270 |
| 66 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.34287460 |
| 67 | FUS_26573619_Chip-Seq_HEK293_Human | 1.34010011 |
| 68 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32573256 |
| 69 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28585861 |
| 70 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.26390472 |
| 71 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.26068700 |
| 72 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.25400802 |
| 73 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25317956 |
| 74 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23361626 |
| 75 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23276751 |
| 76 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21476722 |
| 77 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21291811 |
| 78 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16361085 |
| 79 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15157271 |
| 80 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14790308 |
| 81 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14635670 |
| 82 | * AR_19668381_ChIP-Seq_PC3_Human | 1.12233237 |
| 83 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.11993063 |
| 84 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11796462 |
| 85 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10520028 |
| 86 | VDR_22108803_ChIP-Seq_LS180_Human | 1.09480460 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09202776 |
| 88 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08813513 |
| 89 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.08583811 |
| 90 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.07340268 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06846344 |
| 92 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.06809188 |
| 93 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.06667322 |
| 94 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04697799 |
| 95 | JUN_21703547_ChIP-Seq_K562_Human | 1.04592019 |
| 96 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04389143 |
| 97 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04234721 |
| 98 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04234721 |
| 99 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.03897212 |
| 100 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03473019 |
| 101 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02637220 |
| 102 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01179447 |
| 103 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00176023 |
| 104 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.99435710 |
| 105 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.99435710 |
| 106 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.99345632 |
| 107 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99200341 |
| 108 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.98388200 |
| 109 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98118258 |
| 110 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97795834 |
| 111 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97339610 |
| 112 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97302298 |
| 113 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.97094849 |
| 114 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94619427 |
| 115 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94577619 |
| 116 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94551770 |
| 117 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93127413 |
| 118 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92923858 |
| 119 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90335989 |
| 120 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89485755 |
| 121 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86837479 |
| 122 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86670891 |
| 123 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.86433633 |
| 124 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.84556760 |
| 125 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84002351 |
| 126 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.83724948 |
| 127 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.83608820 |
| 128 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83608820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.88683279 |
| 2 | MP0003880_abnormal_central_pattern | 4.94845872 |
| 3 | MP0009379_abnormal_foot_pigmentation | 4.74545929 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.06914388 |
| 5 | MP0006292_abnormal_olfactory_placode | 3.76286611 |
| 6 | MP0009745_abnormal_behavioral_response | 3.54520739 |
| 7 | MP0004270_analgesia | 3.52391278 |
| 8 | MP0003136_yellow_coat_color | 3.51173269 |
| 9 | MP0002064_seizures | 3.39809783 |
| 10 | MP0002063_abnormal_learning/memory/cond | 3.26746414 |
| 11 | MP0001968_abnormal_touch/_nociception | 3.22131376 |
| 12 | MP0009046_muscle_twitch | 3.21548815 |
| 13 | MP0002822_catalepsy | 3.16295502 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.90944292 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.78596702 |
| 16 | MP0002736_abnormal_nociception_after | 2.71064416 |
| 17 | MP0002272_abnormal_nervous_system | 2.65955550 |
| 18 | MP0001486_abnormal_startle_reflex | 2.47823649 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.39943903 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.36179786 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.34182000 |
| 22 | MP0004133_heterotaxia | 2.32579999 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.27769120 |
| 24 | MP0003890_abnormal_embryonic-extraembry | 2.21372788 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 2.12170536 |
| 26 | MP0002733_abnormal_thermal_nociception | 2.09666116 |
| 27 | MP0002067_abnormal_sensory_capabilities | 2.07437816 |
| 28 | MP0001970_abnormal_pain_threshold | 2.07112058 |
| 29 | MP0005646_abnormal_pituitary_gland | 2.00692143 |
| 30 | MP0000569_abnormal_digit_pigmentation | 1.95109891 |
| 31 | MP0002277_abnormal_respiratory_mucosa | 1.92334738 |
| 32 | MP0000566_synostosis | 1.89972407 |
| 33 | MP0006276_abnormal_autonomic_nervous | 1.85769005 |
| 34 | MP0008569_lethality_at_weaning | 1.83109535 |
| 35 | MP0003011_delayed_dark_adaptation | 1.79034938 |
| 36 | MP0003787_abnormal_imprinting | 1.76181932 |
| 37 | MP0001984_abnormal_olfaction | 1.72306015 |
| 38 | MP0005386_behavior/neurological_phenoty | 1.71899802 |
| 39 | MP0004924_abnormal_behavior | 1.71899802 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.71800474 |
| 41 | MP0002184_abnormal_innervation | 1.70856607 |
| 42 | MP0000778_abnormal_nervous_system | 1.67985420 |
| 43 | MP0003329_amyloid_beta_deposits | 1.66354097 |
| 44 | MP0004858_abnormal_nervous_system | 1.65068322 |
| 45 | MP0002938_white_spotting | 1.63883976 |
| 46 | MP0003879_abnormal_hair_cell | 1.63651830 |
| 47 | MP0004811_abnormal_neuron_physiology | 1.58239034 |
| 48 | MP0003122_maternal_imprinting | 1.57212979 |
| 49 | MP0001529_abnormal_vocalization | 1.56323803 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 1.51843401 |
| 51 | MP0006072_abnormal_retinal_apoptosis | 1.51772102 |
| 52 | MP0001905_abnormal_dopamine_level | 1.51710009 |
| 53 | MP0000049_abnormal_middle_ear | 1.50400341 |
| 54 | MP0001293_anophthalmia | 1.48540518 |
| 55 | MP0003938_abnormal_ear_development | 1.48063980 |
| 56 | MP0000955_abnormal_spinal_cord | 1.42177435 |
| 57 | MP0004142_abnormal_muscle_tone | 1.41957449 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.40935236 |
| 59 | MP0010386_abnormal_urinary_bladder | 1.40703989 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.40162537 |
| 61 | MP0005645_abnormal_hypothalamus_physiol | 1.37105944 |
| 62 | MP0002882_abnormal_neuron_morphology | 1.35212393 |
| 63 | MP0003633_abnormal_nervous_system | 1.30590727 |
| 64 | MP0003567_abnormal_fetal_cardiomyocyte | 1.25619208 |
| 65 | MP0001502_abnormal_circadian_rhythm | 1.24034025 |
| 66 | MP0005174_abnormal_tail_pigmentation | 1.20998968 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 1.16742166 |
| 68 | MP0001188_hyperpigmentation | 1.16347218 |
| 69 | MP0003119_abnormal_digestive_system | 1.13983840 |
| 70 | MP0004885_abnormal_endolymph | 1.13175148 |
| 71 | MP0003631_nervous_system_phenotype | 1.12874091 |
| 72 | MP0008872_abnormal_physiological_respon | 1.11849367 |
| 73 | MP0003937_abnormal_limbs/digits/tail_de | 1.11077548 |
| 74 | MP0003195_calcinosis | 1.10414414 |
| 75 | MP0001986_abnormal_taste_sensitivity | 1.09866951 |
| 76 | MP0002102_abnormal_ear_morphology | 1.09645324 |
| 77 | MP0002876_abnormal_thyroid_physiology | 1.08439572 |
| 78 | MP0002160_abnormal_reproductive_system | 1.06355060 |
| 79 | MP0009250_abnormal_appendicular_skeleto | 1.06054551 |
| 80 | MP0000751_myopathy | 1.03489751 |
| 81 | MP0003183_abnormal_peptide_metabolism | 1.02619464 |
| 82 | MP0002152_abnormal_brain_morphology | 1.01763037 |
| 83 | MP0008995_early_reproductive_senescence | 1.01007899 |
| 84 | MP0010030_abnormal_orbit_morphology | 1.00427282 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 0.99697487 |
| 86 | MP0005171_absent_coat_pigmentation | 0.99331708 |
| 87 | MP0000013_abnormal_adipose_tissue | 0.97626201 |
| 88 | MP0003941_abnormal_skin_development | 0.96502359 |
| 89 | MP0002069_abnormal_eating/drinking_beha | 0.95144338 |
| 90 | MP0002638_abnormal_pupillary_reflex | 0.95127958 |
| 91 | MP0005195_abnormal_posterior_eye | 0.92374351 |
| 92 | MP0002229_neurodegeneration | 0.92015746 |
| 93 | MP0005389_reproductive_system_phenotype | 0.91455363 |
| 94 | MP0005253_abnormal_eye_physiology | 0.89758800 |
| 95 | MP0004742_abnormal_vestibular_system | 0.89094292 |
| 96 | MP0001963_abnormal_hearing_physiology | 0.88825804 |
| 97 | MP0001177_atelectasis | 0.88198206 |
| 98 | MP0008874_decreased_physiological_sensi | 0.87316384 |
| 99 | MP0001286_abnormal_eye_development | 0.84911933 |
| 100 | MP0005535_abnormal_body_temperature | 0.84758136 |
| 101 | MP0002282_abnormal_trachea_morphology | 0.83899646 |
| 102 | MP0003861_abnormal_nervous_system | 0.83385488 |
| 103 | MP0004085_abnormal_heartbeat | 0.83258506 |
| 104 | MP0003315_abnormal_perineum_morphology | 0.81948545 |
| 105 | MP0002928_abnormal_bile_duct | 0.80181770 |
| 106 | MP0003634_abnormal_glial_cell | 0.78478285 |
| 107 | MP0003632_abnormal_nervous_system | 0.77893344 |
| 108 | MP0003718_maternal_effect | 0.77028301 |
| 109 | MP0004043_abnormal_pH_regulation | 0.76925089 |
| 110 | MP0001664_abnormal_digestion | 0.76804203 |
| 111 | MP0004215_abnormal_myocardial_fiber | 0.76225170 |
| 112 | MP0000631_abnormal_neuroendocrine_gland | 0.75165342 |
| 113 | MP0002090_abnormal_vision | 0.74397192 |
| 114 | MP0005499_abnormal_olfactory_system | 0.73302502 |
| 115 | MP0005394_taste/olfaction_phenotype | 0.73302502 |
| 116 | MP0002752_abnormal_somatic_nervous | 0.72048000 |
| 117 | MP0003942_abnormal_urinary_system | 0.71021410 |
| 118 | MP0004145_abnormal_muscle_electrophysio | 0.70569826 |
| 119 | MP0003638_abnormal_response/metabolism_ | 0.70436290 |
| 120 | MP0005503_abnormal_tendon_morphology | 0.70063952 |
| 121 | MP0000604_amyloidosis | 0.68738836 |
| 122 | MP0005187_abnormal_penis_morphology | 0.66754974 |
| 123 | MP0000920_abnormal_myelination | 0.66111810 |
| 124 | MP0004484_altered_response_of | 0.63204744 |
| 125 | MP0001943_abnormal_respiration | 0.61378533 |
| 126 | MP0003690_abnormal_glial_cell | 0.60639081 |
| 127 | MP0002653_abnormal_ependyma_morphology | 0.58539572 |
| 128 | MP0002751_abnormal_autonomic_nervous | 0.55532155 |
| 129 | MP0001485_abnormal_pinna_reflex | 0.54526561 |
| 130 | MP0005623_abnormal_meninges_morphology | 0.52924820 |
| 131 | MP0003283_abnormal_digestive_organ | 0.52294141 |
| 132 | MP0003075_altered_response_to | 0.52069217 |
| 133 | MP0002082_postnatal_lethality | 0.51914913 |
| 134 | MP0010770_preweaning_lethality | 0.51914913 |
| 135 | MP0005379_endocrine/exocrine_gland_phen | 0.51172020 |
| 136 | MP0010769_abnormal_survival | 0.50570950 |
| 137 | MP0000026_abnormal_inner_ear | 0.50514655 |
| 138 | MP0003121_genomic_imprinting | 0.50446566 |
| 139 | MP0008877_abnormal_DNA_methylation | 0.49192044 |
| 140 | MP0003956_abnormal_body_size | 0.48674034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.53579719 |
| 2 | Myokymia (HP:0002411) | 6.45374775 |
| 3 | Focal seizures (HP:0007359) | 5.80411186 |
| 4 | Atonic seizures (HP:0010819) | 5.72993988 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.57815234 |
| 6 | Febrile seizures (HP:0002373) | 5.15541498 |
| 7 | Visual hallucinations (HP:0002367) | 4.95292585 |
| 8 | Absence seizures (HP:0002121) | 4.62329051 |
| 9 | Dialeptic seizures (HP:0011146) | 4.28339579 |
| 10 | Hyperventilation (HP:0002883) | 4.28073939 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 4.24910306 |
| 12 | Congenital, generalized hypertrichosis (HP:0004540) | 4.17971037 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 4.12349005 |
| 14 | Birth length less than 3rd percentile (HP:0003561) | 3.69357896 |
| 15 | Broad-based gait (HP:0002136) | 3.55891372 |
| 16 | Septo-optic dysplasia (HP:0100842) | 3.55869920 |
| 17 | Gaze-evoked nystagmus (HP:0000640) | 3.37712723 |
| 18 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.27570790 |
| 19 | Abnormality of midbrain morphology (HP:0002418) | 3.18116795 |
| 20 | Molar tooth sign on MRI (HP:0002419) | 3.18116795 |
| 21 | Amblyopia (HP:0000646) | 3.15967021 |
| 22 | Pancreatic fibrosis (HP:0100732) | 3.15653755 |
| 23 | Congenital stationary night blindness (HP:0007642) | 3.14108810 |
| 24 | True hermaphroditism (HP:0010459) | 3.12998732 |
| 25 | Abnormal eating behavior (HP:0100738) | 3.10486001 |
| 26 | Pancreatic cysts (HP:0001737) | 3.10285526 |
| 27 | Action tremor (HP:0002345) | 3.09677907 |
| 28 | Poor eye contact (HP:0000817) | 3.08299708 |
| 29 | Ankle clonus (HP:0011448) | 2.99351800 |
| 30 | Bilateral microphthalmos (HP:0007633) | 2.96418539 |
| 31 | Abnormal number of erythroid precursors (HP:0012131) | 2.96232549 |
| 32 | Dysdiadochokinesis (HP:0002075) | 2.95228618 |
| 33 | Depression (HP:0000716) | 2.92869726 |
| 34 | Large for gestational age (HP:0001520) | 2.87949850 |
| 35 | Truncal ataxia (HP:0002078) | 2.85217654 |
| 36 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.83735257 |
| 37 | Abnormality of alanine metabolism (HP:0010916) | 2.83735257 |
| 38 | Hyperalaninemia (HP:0003348) | 2.83735257 |
| 39 | Anxiety (HP:0000739) | 2.83655722 |
| 40 | Epileptiform EEG discharges (HP:0011182) | 2.83212685 |
| 41 | Abnormal social behavior (HP:0012433) | 2.82893764 |
| 42 | Impaired social interactions (HP:0000735) | 2.82893764 |
| 43 | Pheochromocytoma (HP:0002666) | 2.82864285 |
| 44 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.80692835 |
| 45 | Progressive inability to walk (HP:0002505) | 2.79996471 |
| 46 | Dysmetria (HP:0001310) | 2.78474407 |
| 47 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.77688560 |
| 48 | Nephronophthisis (HP:0000090) | 2.70950112 |
| 49 | Excessive salivation (HP:0003781) | 2.70841603 |
| 50 | Drooling (HP:0002307) | 2.70841603 |
| 51 | Pendular nystagmus (HP:0012043) | 2.70060461 |
| 52 | Acute necrotizing encephalopathy (HP:0006965) | 2.69894540 |
| 53 | Absent/shortened dynein arms (HP:0200106) | 2.69257674 |
| 54 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.69257674 |
| 55 | Polyphagia (HP:0002591) | 2.66792399 |
| 56 | Supranuclear gaze palsy (HP:0000605) | 2.65796273 |
| 57 | EEG with generalized epileptiform discharges (HP:0011198) | 2.64461240 |
| 58 | Increased hepatocellular lipid droplets (HP:0006565) | 2.61049865 |
| 59 | Neuroendocrine neoplasm (HP:0100634) | 2.53024454 |
| 60 | Postural instability (HP:0002172) | 2.52043661 |
| 61 | Hypsarrhythmia (HP:0002521) | 2.50302024 |
| 62 | Fetal akinesia sequence (HP:0001989) | 2.48805894 |
| 63 | Absent speech (HP:0001344) | 2.48715930 |
| 64 | Termporal pattern (HP:0011008) | 2.47626336 |
| 65 | Insidious onset (HP:0003587) | 2.47626336 |
| 66 | Patellar aplasia (HP:0006443) | 2.46155567 |
| 67 | Anophthalmia (HP:0000528) | 2.45777153 |
| 68 | Optic nerve hypoplasia (HP:0000609) | 2.45240853 |
| 69 | Blue irides (HP:0000635) | 2.44304511 |
| 70 | Gait imbalance (HP:0002141) | 2.44065567 |
| 71 | Inability to walk (HP:0002540) | 2.43433700 |
| 72 | Limb dystonia (HP:0002451) | 2.43134800 |
| 73 | Abnormality of the lower motor neuron (HP:0002366) | 2.38113531 |
| 74 | Abnormal hair whorl (HP:0010721) | 2.38070293 |
| 75 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.35856717 |
| 76 | Abnormality of binocular vision (HP:0011514) | 2.35566020 |
| 77 | Diplopia (HP:0000651) | 2.35566020 |
| 78 | Urinary urgency (HP:0000012) | 2.35556266 |
| 79 | Acute encephalopathy (HP:0006846) | 2.33965317 |
| 80 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.33623643 |
| 81 | Abnormality of the lacrimal duct (HP:0011481) | 2.33330617 |
| 82 | Spastic gait (HP:0002064) | 2.33268663 |
| 83 | Dysmetric saccades (HP:0000641) | 2.32299723 |
| 84 | Impaired vibratory sensation (HP:0002495) | 2.31528397 |
| 85 | Mutism (HP:0002300) | 2.30114793 |
| 86 | Mitochondrial inheritance (HP:0001427) | 2.29896606 |
| 87 | Bradykinesia (HP:0002067) | 2.28973510 |
| 88 | Focal dystonia (HP:0004373) | 2.28007197 |
| 89 | Maternal diabetes (HP:0009800) | 2.27776546 |
| 90 | Progressive macrocephaly (HP:0004481) | 2.27257783 |
| 91 | Torticollis (HP:0000473) | 2.26076195 |
| 92 | Nasolacrimal duct obstruction (HP:0000579) | 2.25580096 |
| 93 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.25275246 |
| 94 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.25275246 |
| 95 | Abnormal number of incisors (HP:0011064) | 2.25131824 |
| 96 | Hypothermia (HP:0002045) | 2.25108091 |
| 97 | Hemiparesis (HP:0001269) | 2.24539329 |
| 98 | Impaired smooth pursuit (HP:0007772) | 2.24261670 |
| 99 | Abnormality of the corticospinal tract (HP:0002492) | 2.24110976 |
| 100 | Lipid accumulation in hepatocytes (HP:0006561) | 2.23682048 |
| 101 | Scanning speech (HP:0002168) | 2.23236868 |
| 102 | Abnormality of the axillary hair (HP:0100134) | 2.23200949 |
| 103 | Abnormality of secondary sexual hair (HP:0009888) | 2.23200949 |
| 104 | Genetic anticipation (HP:0003743) | 2.21962649 |
| 105 | Abnormality of the nasolacrimal system (HP:0000614) | 2.21746838 |
| 106 | Papilledema (HP:0001085) | 2.21635808 |
| 107 | Renal Fanconi syndrome (HP:0001994) | 2.21134611 |
| 108 | Furrowed tongue (HP:0000221) | 2.19592577 |
| 109 | Hyperthyroidism (HP:0000836) | 2.19466046 |
| 110 | Generalized myoclonic seizures (HP:0002123) | 2.19358304 |
| 111 | Decreased circulating renin level (HP:0003351) | 2.18904526 |
| 112 | Status epilepticus (HP:0002133) | 2.18635769 |
| 113 | Short hallux (HP:0010109) | 2.17599309 |
| 114 | Sclerocornea (HP:0000647) | 2.17416202 |
| 115 | Optic disc pallor (HP:0000543) | 2.15158182 |
| 116 | Poor suck (HP:0002033) | 2.13474186 |
| 117 | Abnormality of the renal medulla (HP:0100957) | 2.12676261 |
| 118 | Congenital primary aphakia (HP:0007707) | 2.12631573 |
| 119 | Specific learning disability (HP:0001328) | 2.12110990 |
| 120 | Absent septum pellucidum (HP:0001331) | 2.12109523 |
| 121 | Failure to thrive in infancy (HP:0001531) | 2.10585953 |
| 122 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.09945609 |
| 123 | Agitation (HP:0000713) | 2.07684073 |
| 124 | Protruding tongue (HP:0010808) | 2.07220615 |
| 125 | Medial flaring of the eyebrow (HP:0010747) | 2.06898783 |
| 126 | Macrocytic anemia (HP:0001972) | 2.04498441 |
| 127 | Gait ataxia (HP:0002066) | 2.03561797 |
| 128 | Nephrogenic diabetes insipidus (HP:0009806) | 2.03289484 |
| 129 | Rib fusion (HP:0000902) | 2.00999440 |
| 130 | Resting tremor (HP:0002322) | 2.00009551 |
| 131 | Confusion (HP:0001289) | 1.99190152 |
| 132 | Increased corneal curvature (HP:0100692) | 1.98565543 |
| 133 | Keratoconus (HP:0000563) | 1.98565543 |
| 134 | Male pseudohermaphroditism (HP:0000037) | 1.98123246 |
| 135 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.96836101 |
| 136 | Hypoventilation (HP:0002791) | 1.96765687 |
| 137 | Stereotypic behavior (HP:0000733) | 1.96758804 |
| 138 | Craniofacial dystonia (HP:0012179) | 1.95493795 |
| 139 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.95423598 |
| 140 | Type II lissencephaly (HP:0007260) | 1.94671228 |
| 141 | Hemiplegia (HP:0002301) | 1.94032444 |
| 142 | Concave nail (HP:0001598) | 1.94031099 |
| 143 | Lower limb muscle weakness (HP:0007340) | 1.93922457 |
| 144 | Cerebral inclusion bodies (HP:0100314) | 1.93368503 |
| 145 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.93152714 |
| 146 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.93152714 |
| 147 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.92805201 |
| 148 | Esophageal atresia (HP:0002032) | 1.92763706 |
| 149 | Clumsiness (HP:0002312) | 1.92529390 |
| 150 | Incomplete penetrance (HP:0003829) | 1.92381631 |
| 151 | Acute lymphatic leukemia (HP:0006721) | 1.92034429 |
| 152 | Abolished electroretinogram (ERG) (HP:0000550) | 1.90204022 |
| 153 | Abnormality of salivation (HP:0100755) | 1.90003966 |
| 154 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.89620472 |
| 155 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.89441233 |
| 156 | Neurofibrillary tangles (HP:0002185) | 1.87276622 |
| 157 | Chorioretinal atrophy (HP:0000533) | 1.87002128 |
| 158 | Exertional dyspnea (HP:0002875) | 1.86866427 |
| 159 | Intention tremor (HP:0002080) | 1.85522561 |
| 160 | Increased CSF lactate (HP:0002490) | 1.83684468 |
| 161 | Abnormal ciliary motility (HP:0012262) | 1.83468732 |
| 162 | Cystic liver disease (HP:0006706) | 1.83263446 |
| 163 | Psychosis (HP:0000709) | 1.83124198 |
| 164 | Pallor (HP:0000980) | 1.81373441 |
| 165 | Sensory axonal neuropathy (HP:0003390) | 1.81121658 |
| 166 | Abnormality of renal resorption (HP:0011038) | 1.80832976 |
| 167 | Akinesia (HP:0002304) | 1.80692295 |
| 168 | Postural tremor (HP:0002174) | 1.80581085 |
| 169 | Abnormality of the pons (HP:0007361) | 1.80429814 |
| 170 | Methylmalonic acidemia (HP:0002912) | 1.80036913 |
| 171 | Oral leukoplakia (HP:0002745) | 1.79467513 |
| 172 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.77519637 |
| 173 | Abnormality of the septum pellucidum (HP:0007375) | 1.77359080 |
| 174 | Sleep apnea (HP:0010535) | 1.76150617 |
| 175 | Esotropia (HP:0000565) | 1.75410756 |
| 176 | Megalencephaly (HP:0001355) | 1.75262329 |
| 177 | Hypoplasia of the pons (HP:0012110) | 1.74939357 |
| 178 | Vaginal atresia (HP:0000148) | 1.74181095 |
| 179 | Genital tract atresia (HP:0001827) | 1.74156155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.24202647 |
| 2 | NTRK3 | 4.13410627 |
| 3 | MAP3K4 | 3.38116381 |
| 4 | EPHA4 | 3.27132057 |
| 5 | MAP3K9 | 3.22691699 |
| 6 | BMPR1B | 3.22043401 |
| 7 | ACVR1B | 3.13731448 |
| 8 | MAP2K7 | 3.07805308 |
| 9 | MAP3K12 | 3.06510295 |
| 10 | DAPK2 | 2.78981659 |
| 11 | ZAK | 2.68535566 |
| 12 | DYRK2 | 2.62010110 |
| 13 | MARK1 | 2.36606253 |
| 14 | CDK19 | 2.33399899 |
| 15 | MINK1 | 2.29930609 |
| 16 | MAP2K4 | 2.13986215 |
| 17 | MKNK2 | 2.00370835 |
| 18 | PAK6 | 1.88982761 |
| 19 | NTRK2 | 1.88875907 |
| 20 | DAPK1 | 1.87296124 |
| 21 | PRPF4B | 1.82716650 |
| 22 | PLK2 | 1.78815983 |
| 23 | TAF1 | 1.77364546 |
| 24 | NTRK1 | 1.76058867 |
| 25 | TLK1 | 1.74992863 |
| 26 | GRK1 | 1.70334660 |
| 27 | KSR2 | 1.69485877 |
| 28 | FRK | 1.67785821 |
| 29 | GRK5 | 1.65692120 |
| 30 | ARAF | 1.50523151 |
| 31 | OXSR1 | 1.47321431 |
| 32 | MAPK15 | 1.46244528 |
| 33 | PBK | 1.44226420 |
| 34 | CDK5 | 1.40635815 |
| 35 | BCKDK | 1.39998267 |
| 36 | KSR1 | 1.38999098 |
| 37 | MAPK13 | 1.38288208 |
| 38 | PRKD3 | 1.36127158 |
| 39 | INSRR | 1.35456840 |
| 40 | CAMKK1 | 1.32471472 |
| 41 | VRK1 | 1.31472762 |
| 42 | RIPK4 | 1.31364369 |
| 43 | CDC7 | 1.30289196 |
| 44 | TNIK | 1.29096920 |
| 45 | PNCK | 1.27734739 |
| 46 | PRKCG | 1.24459598 |
| 47 | AKT3 | 1.21620170 |
| 48 | CCNB1 | 1.16995216 |
| 49 | TGFBR1 | 1.14886160 |
| 50 | WNK4 | 1.12922011 |
| 51 | SGK223 | 1.11230767 |
| 52 | SGK494 | 1.11230767 |
| 53 | MKNK1 | 1.09440846 |
| 54 | BUB1 | 1.08798082 |
| 55 | DYRK3 | 1.08205355 |
| 56 | UHMK1 | 1.07675792 |
| 57 | CAMK2A | 1.04578092 |
| 58 | TIE1 | 1.04251347 |
| 59 | FES | 1.02047130 |
| 60 | MAP3K13 | 1.00582062 |
| 61 | CAMKK2 | 0.99393238 |
| 62 | LMTK2 | 0.98318167 |
| 63 | STK16 | 0.95667559 |
| 64 | SGK2 | 0.93246110 |
| 65 | MAP3K2 | 0.92985795 |
| 66 | VRK2 | 0.92455444 |
| 67 | STK38 | 0.91084407 |
| 68 | CDK18 | 0.89767209 |
| 69 | CAMK2B | 0.87552550 |
| 70 | SIK2 | 0.87403067 |
| 71 | PTK2B | 0.87108608 |
| 72 | CDK15 | 0.85306301 |
| 73 | NEK2 | 0.84727084 |
| 74 | CDK14 | 0.82319924 |
| 75 | TYRO3 | 0.80680727 |
| 76 | WEE1 | 0.80090384 |
| 77 | PHKG1 | 0.79107756 |
| 78 | PHKG2 | 0.79107756 |
| 79 | SIK3 | 0.78329109 |
| 80 | CAMK1 | 0.78326354 |
| 81 | NME1 | 0.78142759 |
| 82 | RPS6KA5 | 0.76073434 |
| 83 | BMPR2 | 0.75760518 |
| 84 | CDK11A | 0.72970917 |
| 85 | PRKCE | 0.72438616 |
| 86 | GRK7 | 0.72429469 |
| 87 | PLK3 | 0.70800393 |
| 88 | PRKCH | 0.69571942 |
| 89 | TSSK6 | 0.67848973 |
| 90 | STK11 | 0.66836793 |
| 91 | CDK3 | 0.66308420 |
| 92 | SGK3 | 0.65056542 |
| 93 | PAK3 | 0.64395346 |
| 94 | PDK3 | 0.63852208 |
| 95 | PDK4 | 0.63852208 |
| 96 | CSNK1G2 | 0.63762420 |
| 97 | NUAK1 | 0.63324295 |
| 98 | PLK4 | 0.62927513 |
| 99 | DYRK1A | 0.61977525 |
| 100 | RET | 0.61251291 |
| 101 | BRAF | 0.60946686 |
| 102 | RPS6KA6 | 0.60142182 |
| 103 | RAF1 | 0.57899224 |
| 104 | PKN1 | 0.57688231 |
| 105 | SGK1 | 0.57418411 |
| 106 | MAP3K1 | 0.57064145 |
| 107 | MUSK | 0.56781146 |
| 108 | DAPK3 | 0.55482812 |
| 109 | PDK1 | 0.55213715 |
| 110 | PLK1 | 0.54085964 |
| 111 | LATS2 | 0.53810142 |
| 112 | WNK3 | 0.53496423 |
| 113 | FER | 0.52570538 |
| 114 | CAMK2D | 0.52245643 |
| 115 | PINK1 | 0.51585121 |
| 116 | PRKACA | 0.50957775 |
| 117 | CAMK1G | 0.50866932 |
| 118 | ADRBK1 | 0.50860496 |
| 119 | PDPK1 | 0.50561196 |
| 120 | CAMK2G | 0.50548486 |
| 121 | MAP2K1 | 0.50311457 |
| 122 | CHUK | 0.49541809 |
| 123 | CHEK2 | 0.49537387 |
| 124 | TAOK1 | 0.47454844 |
| 125 | TNK2 | 0.46341303 |
| 126 | MAPKAPK5 | 0.44801814 |
| 127 | BCR | 0.44449442 |
| 128 | FGR | 0.43784796 |
| 129 | MAP3K6 | 0.41664488 |
| 130 | CSNK1E | 0.41056555 |
| 131 | RPS6KA3 | 0.40389392 |
| 132 | NEK6 | 0.40156457 |
| 133 | TAOK3 | 0.39788918 |
| 134 | PIM1 | 0.36997983 |
| 135 | CAMK4 | 0.36561464 |
| 136 | PRKG1 | 0.36339122 |
| 137 | PRKCZ | 0.35434754 |
| 138 | MARK2 | 0.35352405 |
| 139 | PRKACB | 0.35308169 |
| 140 | ERBB4 | 0.34607136 |
| 141 | EPHB2 | 0.34354711 |
| 142 | ROCK2 | 0.34354487 |
| 143 | ADRBK2 | 0.34074800 |
| 144 | MATK | 0.33595984 |
| 145 | MAP3K11 | 0.33258341 |
| 146 | TEC | 0.33212729 |
| 147 | PRKG2 | 0.32932074 |
| 148 | KIT | 0.32468347 |
| 149 | STK38L | 0.32128619 |
| 150 | OBSCN | 0.30149624 |
| 151 | PIK3CA | 0.28178108 |
| 152 | ALK | 0.27961080 |
| 153 | RPS6KA4 | 0.27693152 |
| 154 | WNK1 | 0.26728379 |
| 155 | YES1 | 0.26260853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.00733232 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.92371466 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.46355350 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.81854228 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.77297285 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.69038025 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.58903672 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.52934964 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.48104276 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.44171907 |
| 11 | * Olfactory transduction_Homo sapiens_hsa04740 | 2.42045580 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.39627917 |
| 13 | RNA polymerase_Homo sapiens_hsa03020 | 2.19502984 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.15856633 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.11017624 |
| 16 | Protein export_Homo sapiens_hsa03060 | 2.10490477 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.09152903 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09137437 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 2.08668613 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 2.06957638 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.98902948 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.93886666 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.91517202 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.82167718 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81371280 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.77860436 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.75180270 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.74787515 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.72477677 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.66353348 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.63459750 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.51178992 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.51145365 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.49843166 |
| 35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.47708705 |
| 36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.47500437 |
| 37 | Basal transcription factors_Homo sapiens_hsa03022 | 1.42322221 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.33174468 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.31181856 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28417172 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.27677744 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.24522018 |
| 43 | Gap junction_Homo sapiens_hsa04540 | 1.24258959 |
| 44 | Homologous recombination_Homo sapiens_hsa03440 | 1.21238999 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16991386 |
| 46 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.16213287 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16096403 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.15847229 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.14696175 |
| 50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.13526891 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.13031141 |
| 52 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10677544 |
| 53 | RNA degradation_Homo sapiens_hsa03018 | 1.09095991 |
| 54 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.06907975 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06508979 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.03645668 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.01540912 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00922304 |
| 59 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00032522 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.99601693 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98912959 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.95947203 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94719239 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 0.92567383 |
| 65 | Melanogenesis_Homo sapiens_hsa04916 | 0.91454113 |
| 66 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91374236 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90194330 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.87293064 |
| 69 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.86552322 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.86375606 |
| 71 | Proteasome_Homo sapiens_hsa03050 | 0.86276213 |
| 72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85090675 |
| 73 | Alzheimers disease_Homo sapiens_hsa05010 | 0.82889035 |
| 74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81649849 |
| 75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.81312486 |
| 76 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.80193761 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79219589 |
| 78 | Phototransduction_Homo sapiens_hsa04744 | 0.77936502 |
| 79 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.77865267 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76313500 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74166378 |
| 82 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72898701 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70663214 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70211990 |
| 85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.69886549 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69028988 |
| 87 | Spliceosome_Homo sapiens_hsa03040 | 0.67562476 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67115232 |
| 89 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66433190 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65208252 |
| 91 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.64298576 |
| 92 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63346537 |
| 93 | Purine metabolism_Homo sapiens_hsa00230 | 0.63048988 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62504288 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61263068 |
| 96 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60742851 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59445468 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58289332 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56909209 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54120393 |
| 101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52282651 |
| 102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52089480 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51474653 |
| 104 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.50281544 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49513295 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49496617 |
| 107 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.48864520 |
| 108 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.48578011 |
| 109 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48535876 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.48181326 |
| 111 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.46824342 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46582424 |
| 113 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.46043792 |
| 114 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.45626651 |
| 115 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.43850807 |
| 116 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42695926 |
| 117 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.41679150 |
| 118 | Alcoholism_Homo sapiens_hsa05034 | 0.41415666 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41181844 |
| 120 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41067217 |
| 121 | Phagosome_Homo sapiens_hsa04145 | 0.40852673 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40560590 |
| 123 | Bile secretion_Homo sapiens_hsa04976 | 0.40479937 |
| 124 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.40115084 |
| 125 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39869984 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.39544358 |
| 127 | Peroxisome_Homo sapiens_hsa04146 | 0.39235059 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39023314 |
| 129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38426496 |
| 130 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37405610 |
| 131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36806028 |
| 132 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.34531656 |
| 133 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34226158 |
| 134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33623701 |
| 135 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.33194561 |
| 136 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.33079816 |
| 137 | ABC transporters_Homo sapiens_hsa02010 | 0.32324120 |
| 138 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.31999454 |
| 139 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.31962582 |
| 140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31748016 |
| 141 | Endocytosis_Homo sapiens_hsa04144 | 0.31469028 |
| 142 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31291480 |
| 143 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.30954649 |
| 144 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.30134574 |
| 145 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29996920 |
| 146 | Melanoma_Homo sapiens_hsa05218 | 0.29284782 |
| 147 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.29077774 |
| 148 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.28679407 |
| 149 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.28504035 |
| 150 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28284381 |
| 151 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28064387 |
| 152 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.25468755 |
| 153 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.24001853 |

